화학공학소재연구정보센터
Korean Journal of Chemical Engineering, Vol.33, No.9, 2738-2746, September, 2016
Physical characteristics and in vitro skin permeation of elastic liposomes loaded with caffeic acid-hydroxypropyl-β-cyclodextrin
E-mail:
We developed a drug-in-cyclodextrin-in-elastic liposomes (DCEL) system to enhance transdermal delivery of caffeic acid (CA). Hydroxypropyl-β-cyclodextrin (HP-β-CD) was used as a hydrophilic CD. Elastic liposomes (EL) contained polyethylene glycol-free Tego® care 450 as an edge activator. Properties of the CA-HP-β-CD inclusion complex loaded in EL (CD-EL) as DCEL system were compared to characteristics of conventional liposomes (CL), EL, and CD-CL. Particle size, deformability, entrapment efficiency (EE%), stability, and vesicle morphology were characterized in liposome preparations. In addition, in vitro release and skin permeation were analyzed. We found that including Tego® care 450 reduced vesicle size and increased membrane deformability. The addition of HP-β-CD enhanced CA EE% of liposomes almost 1.6-fold that of liposomes without HP-β-CD. Moreover, CD-EL complex showed better controlled release profiles and higher skin permeability than CL and EL. We propose that the DCEL system can be a promising drug delivery vehicle for transdermal delivery of CA.
  1. Honeywell-Nguyen PL, Bouwstra JA, Drug Discovery Today Technol., 2, 67 (2005)
  2. Otto DP, Villiers MM, Ther. Deliv., 5, 961 (2014)
  3. Park SN, Lee MH, Kim SJ, Yu ER, Biochem. Biophys. Res. Commun., 435(3), 361 (2013)
  4. Choi MJ, Maibach HI, Int. J. Cosmet. Sci., 27, 211 (2005)
  5. Cevc G, Blume G, BBA-Biomembranes, 1104, 226 (1992)
  6. Elsayed MA, Abdallah Y, Naggar F, Khalafallah M, Int. J. Pharm., 332, 1 (2007)
  7. Johnson W, Int. J. Toxicol., 20, 13 (2001)
  8. Han SB, Kwon SS, Jeong YM, Kong BJ, Yu ER, Park SN, Polym. Korea, 38(6), 694 (2014)
  9. Park SN, Lim MS, Park MA, Kwon SS, Han SB, Polym. Korea, 36(6), 705 (2012)
  10. Maestrlli F, Gonzalez-Rodriguez ML, Rabasco AM, Ghelardini C, Mura P, Int. J. Pharm., 395, 222 (2010)
  11. Im NR, Kim HS, Lim JW, Kim KJ, Noh GY, Park SN, Appl. Chem. Eng., 26(5), 563 (2015)
  12. Zhang W, Wang G, Falconer JR, Baguley BC, Shaw JP, Liu J, Xu H, See E, Sun J, Aa J, Wu Z, Pharm. Res., 32, 1451 (2015)
  13. McCormack B, Gregoriadis G, Int. J. Pharm., 112, 249 (1994)
  14. Chen J, Lu WL, Gu W, Lu SS, Chen ZP, Cai BC, Yang XX, Expert. Opin Drug. Deliv., 11, 565 (2014)
  15. Chen J, Lu WL, Gu W, Lu SS, Chen ZP, Cai BC, Expert. Opin Drug. Deliv., 10, 845 (2013)
  16. Cal K, Centkowska K, Eur. J. Pharm. Biopharm., 68, 467 (2008)
  17. Kaur N, Puri R, Jain SK, Aaps PharmSciTech, 11, 528 (2010)
  18. Loftsson T, Brewster ME, J. Pharm. Pharmacol., 63, 1119 (2011)
  19. Kang NJ, Lee KW, Shin BJ, Jung SK, Hwang MK, Bode AM, Heo YS, Lee HJ, Dong Z, Carcinogenesis, 30, 321 (2009)
  20. Gupta A, Maheshwari DK, Khandelwal G, J. Appl. Nat. Sci., 5, 459 (2013)
  21. Astorino TA, Alkadhi KA, in Caffeine: chemistry, analysis, function and effects, Preedy VR, Eds., Royal Society of Chemistry (2012).
  22. Kim BY, Jeong JS, Kwon HJ, Lee JH, Hong SP, Kor. J. Herbol., 23, 67 (2008)
  23. Fathi M, Mirlohi M, Varshosaz J, Madani G, J. Nanomater., 2013, 9 (2013)
  24. Zhang M, Li J, Zhang L, Chao J, Spectroc. Acta Pt. A-Molec. Biomolec. Spectr., 71, 1891 (2009)
  25. Mohan PRK, Sreelakshmi G, Muraleedharan CV, Joseph R, Vib. Spectrosc., 62, 77 (2012)
  26. van den Bergh BAI, Wertz PW, Junginger HE, Bouwstra JA, Int. J. Pharm., 217, 13 (2001)
  27. Shaji J, Iyer S, Asian J. Pharm., 6, 218 (2012)
  28. Delrivo A, Zoppi A, Longhi MR, Carbohydr. Polym., 87, 1980 (2012)
  29. Liu B, Zhao J, Liu Y, Zhu X, Zeng J, J. Agric. Food Chem., 60, 12501 (2012)
  30. Gillet A, Lecomte F, Hubert P, Ducat E, Evrard B, Piel G, Eur. J. Pharm. Biopharm., 79, 43 (2011)
  31. Alomrani AH, Shazly GA, Amara AA, Badran MM, Colloids Surf. B: Biointerfaces, 121, 74 (2014)
  32. Guo F, Wang J, Ma M, Tan F, Li N, J. Mater. Sci. -Mater. Med., 26, 1 (2015)
  33. Hommoss A, PhD Thesis, Berlin, Free University of Berlin (2009).
  34. Aggarwal N, Goindi S, Int. J. Pharm., 437, 277 (2012)
  35. El Maghraby GMM, Williams AC, Barry BW, Int. J. Pharm., 276, 143 (2004)
  36. Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, Tan G, He J, Alb A, John V, Pochampally R, Nanomedicine, 8, 440 (2012)
  37. Agashe H, Lagisetty P, Sahoo K, Bourne D, Grady B, Awasthi V, J. Nanopart. Res., 13, 2609 (2011)
  38. Shaji J, Lal M, Int. J. Curr. Pharm. Res., 6, 16 (2014)
  39. Nava G, Pinon E, Mendoza L, Mendoza N, Quintanar D, Ganem A, Pharmaceutics, 3, 954 (2011)
  40. Hussain A, Samad A, Ramzan M, Ahsan MN, Rehman ZU, Ahmad FJ, Drug. Deliv., 14, 1 (2014)
  41. Singh HP, Tiwary AK, Jain S, Yakugaku Zasshi, 130, 397 (2010)
  42. Lira MC, Ferraz MS, da Silva DG, Cortes ME, Teixeira KI, Caetano NP, Santos-Magalhaes NS, J. Incl. Phenom. Macrocycl. Chem., 64, 215 (2009)
  43. Masson M, Loftsson T, Masson G, Stefansson E, J. Control. Release, 59, 107 (1999)
  44. Nagarsenker MS, Amin L, Date AA, AAPS PharmSciTech, 9, 1165 (2008)
  45. Chirio D, Cavalli R, Trotta F, Carlotti ME, Trotta M, J. Incl. Phenom. Macrocycl. Chem., 57, 645 (2007)